Newbridge Financial Services Group’s enVVeno Medical Corporation Warrants NVNOW Stock Holding History

Newbridge Financial Services Group’s Portfolio NVNOW Stock Details NVNOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500	Closed	-$24	–	1464
2023 Q1	$24	Hold	500	–	–	﹤0.01%	1393
2022 Q4	$28	Hold	500	–	–	﹤0.01%	1423
2022 Q3	$0	Hold	500	–	–	﹤0.01%	1513
2022 Q2	$0	Hold	500	–	–	﹤0.01%	1569
2022 Q1	$0	Hold	500	–	–	﹤0.01%	1603
2021 Q4	$0	Hold	500	–	–	﹤0.01%	1575
2021 Q3	$1K	Hold	500	–	–	﹤0.01%	1358
2021 Q2	$0	Hold	500	–	–	﹤0.01%	1536
2021 Q1	$1K	Hold	500	–	–	﹤0.01%	1357
2020 Q4	$1K	Hold	500	–	–	﹤0.01%	1092
2020 Q3	$0	Buy	+500	New	+$59	﹤0.01%	1062

Newbridge Financial Services Group's NVNOW Position: Q2 2023 in Review

Newbridge Financial Services Group sold out of enVVeno Medical Corporation Warrants (NVNOW) in Q2 2023, closing a stake of 500 shares — an estimated $24 sold.

Newbridge Financial Services Group first reported a position in NVNOW in Q3 2020 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 0 funds tracked by Wall St. Rank hold NVNOW as of Q2 2023.

Newbridge Financial Services Group reported no remaining enVVeno Medical Corporation Warrants position as of Q2 2023 after selling out during the quarter.
Newbridge Financial Services Group sold 500 enVVeno Medical Corporation Warrants shares in Q2 2023, an estimated $24.
Newbridge Financial Services Group first reported a position in enVVeno Medical Corporation Warrants in Q3 2020 and held it in 11 quarters.
Newbridge Financial Services Group's enVVeno Medical Corporation Warrants position peaked at $1K in Q3 2021.
0 funds tracked by Wall St. Rank held enVVeno Medical Corporation Warrants as of Q2 2023.

Based on Newbridge Financial Services Group's 13F filing for Q2 2023, filed 21 Jul 2023.